Definitive Analysis
Financial Statements
Periods / Units
Fundamentals
Valuations
Miscellaneous
Analysis Mode
Full Access
See Pricing Start Trial
Multiples Valuation: Revvity, Inc.

Revvity, Inc. (RVTY)

Industry: Medical - Diagnostics & Research Model: Peers Multiples Valuation

Valuation Snapshot

Winsorized Fair Value
Range (Low - High) $31.16 — $61.81
Selected (Average) $49.55
Upside to Live -55.96%
Full Range Fair Value
Range (Low - High) $35.12 — $74.12
Selected (Average) $56.80
Upside to Live -49.51%
Live Price $112.50

Industry Peers Data

TickerRankNameRev TTM (M) Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
SYNH 11 Syneos Health, Inc 5,419 61.34 61.34 14.50 14.37 42.53 24.71
ILMN 12 Illumina, Inc. 4,287 20.39 19.99 12.25 11.75 17.16 19.07
IDXX 13 IDEXX Laboratories 4,167 49.81 43.08 35.28 30.68 36.09 33.84
CRL 14 Charles River Labo 4,024 - - 19.32 20.43 18.64 87.76
WAT 15 Waters Corporation 3,106 26.76 25.45 17.61 16.47 23.93 21.06
EXAS 16 Exact Sciences Cor 3,082 - - - - - -
SYAB.DE 17 Synlab AG 3,071 27.70 27.70 7.78 7.78 17.44 27.50
RVTY 18 Revvity, Inc. 2,813 41.59 46.40 16.04 16.12 37.70 34.70
QIA.DE 19 Qiagen N.V. 2,432 23.67 20.37 12.62 11.54 20.06 19.52
MEDP 20 Medpace Holdings, 2,358 34.47 26.86 28.39 22.62 26.07 22.80
DASA3.SA 21 Diagnósticos da A 2,277 - - 3.95 3.15 5.84 6.20
HLS.AX 22 Healius Limited 2,041 - - - - - 32.34
RDNT 23 RadNet, Inc. 1,970 - - 28.09 26.96 61.49 105.52
4544.T 24 H.U. Group Holding 1,574 133.25 133.25 8.55 7.90 61.88 91.37
300244.SZ 25 Dian Diagnostics G 1,491 - - 20.46 25.74 16.43 -
FLRY3.SA 26 Fleury S.A. 1,462 14.65 11.43 6.25 4.99 9.75 9.48

Implied Valuation Analysis

Line Item Trailing P/EForward P/ETrailing EV/EBITDAForward EV/EBITDATrailing EV/EBITForward EV/EBIT
Winsorized Median Multiple26.7625.4512.6211.7518.6422.80
Full Range Median Multiple27.7026.8614.5014.3720.0624.71
Industry Multiple43.5641.0516.5415.7227.4838.55
Market Implied Multiple55.5762.0020.3720.4747.8744.06
Company (RVTY) Multiple41.5946.4016.0416.1237.7034.70
(*) Net Income / EBITDA / Revenue238214770766328356
Winsorized Enterprise ValueN/AN/A9,7149,0016,1068,116
Full Range Median Enterprise ValueN/AN/A11,16411,0066,5728,794
(-) Net Debt2,4382,4382,4382,4382,4382,438
Winsorized Equity Value6,3795,4367,2776,5643,6695,679
Full Range Median Equity Value6,6025,7388,7268,5694,1346,357
(/) Shares Outstanding118118118118118118
Winsorized Fair Value$54.18$46.17$61.81$55.75$31.16$48.23
Full Range Median Fair Value$56.08$48.74$74.12$72.78$35.12$53.99
Current Price$112.50$112.50$112.50$112.50$112.50$112.50
Upside / Downside-51.84%-58.96%-45.06%-50.44%-72.30%-57.13%
Safety Margin30.0%30.0%30.0%30.0%30.0%30.0%
Buy Price$37.93$32.32$43.26$39.03$21.81$33.76
Buy / Don't BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t BuyDon’t Buy